USING CDK INHIBITORS IN ADVANCED PROSTATE CANCER

被引：0
|
作者：
Pearson, R. [1 ,2 ]
Ng, J. [1 ,2 ]
Anantharaman, A. [2 ]
Pierro, L. [2 ,3 ]
Azam, H. [2 ,3 ]
Prencipe, M. [2 ,3 ]
机构：
[1] Univ Coll Dublin, UCD Sch Med, Dublin 4, Ireland
[2] Univ Coll Dublin, UCD Conway Inst Biomed & Biomol Res, Dublin 4, Ireland
[3] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2019年 / 188卷 / SUPPL 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
28
引用
下载
收藏
页码：S331 / S332
页数：2
相关论文
共 50 条
  • [21] Using PARP Inhibitors in Advanced Ovarian Cancer
    O'Cearbhaill, Roisin E.
    ONCOLOGY-NEW YORK, 2018, 32 (07): : 339 - 343
  • [22] Transcription-regulating kinases CDK8 and CDK19 as novel therapeutic targets for advanced prostate cancer
    Chen, Mengqian
    Kaza, Vimala
    Liang, Jiaxin
    McDermott, Martina
    Roninson, Igor
    CANCER RESEARCH, 2014, 74 (19)
  • [23] PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
    McNevin, Ciara S.
    Cadoo, Karen
    Baird, Anne-Marie
    Finn, Stephen P.
    McDermott, Ray
    CANCERS, 2022, 14 (19)
  • [24] Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
    Offermann, Anne
    Braegelmann, Johannes
    Kluemper, Niklas
    Duensing, Stefan
    Svensson, Maria
    Shaikhibrahim, Zaki
    Kirfel, Jutta
    Perner, Sven
    MODERN PATHOLOGY, 2017, 30 : 247A - 247A
  • [25] Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors
    Bakovic, Matea
    Bago, Martina
    Benic, Lucija
    Krajinovic, Magdalena
    Silovski, Tajana
    Plavetic, Natalija Dedic
    Turkovic, Lu
    Sertic, Miranda
    Hadziabdic, Maja Ortner
    ACTA PHARMACEUTICA, 2023, 73 (04) : 633 - 654
  • [26] Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
    Gabe S. Sonke
    Annemiek van Ommen-Nijhof
    Noor Wortelboer
    Vincent van der Noort
    Astrid C. P. Swinkels
    Hedwig M. Blommestein
    Cristina Guerrero Paez
    Linda Mol
    Aart Beeker
    Karin Beelen
    Lisanne C. Hamming
    Joan B. Heijns
    Aafke H. Honkoop
    Paul C. de Jong
    Quirine C. van Rossum-Schornagel
    Christa van Schaik-van de Mheen
    Jolien Tol
    Cathrien S. Tromp-van Driel
    Suzan Vrijaldenhoven
    A. Elise van Leeuwen-Stok
    Inge R. Konings
    Agnes Jager
    Nature, 2024, 636 (8042) : 474 - 480
  • [27] Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
    Braegelmann, Johannes
    Kluemper, Niklas
    Offermann, Anne
    Von Maessenhausen, Anne
    Boehm, Diana
    Deng, Mario
    Queisser, Angela
    Sanders, Christine
    Syring, Isabella
    Merseburger, Axel S.
    Vogel, Wenzel
    Sievers, Elisabeth
    Vlasic, Ignacija
    Carlsson, Jessica
    Andren, Ove
    Brossart, Peter
    Duensing, Stefan
    Svensson, Maria A.
    Shaikhibrahim, Zaki
    Kirfel, Jutta
    Perner, Sven
    CLINICAL CANCER RESEARCH, 2017, 23 (07) : 1829 - 1840
  • [28] Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
    Offermann, Anne
    Braegelmann, Johannes
    Kluemper, Niklas
    Duensing, Stefan
    Svensson, Maria
    Shaikhibrahim, Zaki
    Kirfel, Julia
    Perner, Sven
    LABORATORY INVESTIGATION, 2017, 97 : 247A - 247A
  • [29] CDK4/6 inhibitors in advanced hormone receptor-positive breast cancer
    Barroso-Sousa, Romualdo
    Tolaney, Sara M.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S205 - S209
  • [30] Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors
    Richters, Andre
    Doyle, Shelby K.
    Freeman, David B.
    Lee, Christina
    Leifer, Becky S.
    Jagannathan, Sajjeev
    Kabinger, Florian
    Koren, Jost Vrabic
    Struntz, Nicholas B.
    Urgiles, Julie
    Stagg, Ryan A.
    Curtin, Brice H.
    Chatterjee, Deep
    Mathea, Sebastian
    Mikochik, Peter J.
    Hopkins, Tamara D.
    Gao, Hua
    Branch, Jonathan R.
    Xin, Hong
    Westover, Lori
    Bignan, Gilles C.
    Rupnow, Brent A.
    Karlin, Kristen L.
    Olson, Calla M.
    Westbrook, Thomas F.
    Vacca, Joseph
    Wilfong, Chris M.
    Trotter, B. Wesley
    Saffran, Douglas C.
    Bischofberger, Norbert
    Knapp, Stefan
    Russo, Joshua W.
    Hickson, Ian
    Bischoff, James R.
    Gottardis, Marco M.
    Balk, Steven P.
    Lin, Charles Y.
    Pop, Marius S.
    Koehler, Angela N.
    CELL CHEMICAL BIOLOGY, 2021, 28 (02) : 134 - +
12345